To jab or not to jab? Here’s why the answer should always be yes

13 Sept 08:24 Key points summarised by AI

Medical experts confirm that COVID-19 vaccination risks are significantly lower than daily activities, with no fatalities among millions vaccinated in Thailand, a stark contrast to daily COVID-19 deaths.
Most vaccine side effects are mild and temporary, such as fever or swelling, with experts assuring that no deaths, disabilities, or permanent health conditions result from the jabs.
The risk of vaccine-related blood clots is not increased for Thais due to genetic factors, and contracting COVID-19 itself poses a far greater threat of clotting than vaccination.
Vaccines offer robust protection, halving infection risk and providing stronger immunity after a second dose, safeguarding individuals and contributing to crucial herd immunity, especially vital for protecting children.
Both AstraZeneca and Sinovac vaccines are deemed effective, and Thailand's mass vaccination program is designed for safety and efficiency, ensuring widespread protection.

Speculation growing over merger between Bhumjaithai and Kla Tham parties

Today 16:46 Key points summarised by AI

A dinner between Bhumjaithai and Kla Tham party leaders sparked rumors of a potential merger, though Bhumjaithai's leader, Anutin, downplayed it as a casual meal.
The meeting is widely interpreted as a strategic message from Bhumjaithai to the Pheu Thai party, signaling alternative support ahead of an upcoming no-confidence debate.
Thailand's Constitution (Section 99) currently prohibits direct mergers of parties with sitting MPs during the House's term, a rule designed to prevent the 'buying and selling' of MPs.
While direct mergers are restricted, MPs can still switch parties if dismissed by a three-fourths party vote or if their party dissolves, allowing for indirect political realignments.
Kla Tham's voting behavior in the censure debate will demonstrate its loyalty to the government, potentially influencing future political dynamics despite current merger restrictions.